 | • レポートコード：GIR-105X03519 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、中枢神経系（CNS）覚醒剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。中枢神経系（CNS）覚醒剤の種類別市場規模（アンフェタミン、コカイン、カフェイン、その他）、用途別市場規模（注意欠陥多動性障害（ADHD）、ナルコレプシー、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・中枢神経系（CNS）覚醒剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Astellas Pharma、Biogen、Celltech、Eli Lilly and Company、GlaxoSmithKline、Johnson and Johnson、Merck、Novartis、Perdue Pharma、Pfizer、Roche、Sanofi、Shire、Takeda Pharmaceuticals、Thermo Fisher Scientific ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アンフェタミン、コカイン、カフェイン、その他 ・用途別分析2016年-2026年：注意欠陥多動性障害（ADHD）、ナルコレプシー、その他 ・中枢神経系（CNS）覚醒剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・中枢神経系（CNS）覚醒剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・中枢神経系（CNS）覚醒剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・中枢神経系（CNS）覚醒剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・中枢神経系（CNS）覚醒剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Central Nervous System (CNS) Stimulant Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Central Nervous System (CNS) Stimulant Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Central Nervous System (CNS) Stimulant Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Central Nervous System (CNS) Stimulant Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Amphetamine
Cocaine
Caffeine
Others
Market segment by Application can be divided into
Attention Deficit Hyperactivity Disorder (ADHD)
Narcolepsy
Others
The key market players for global Central Nervous System (CNS) Stimulant Drugs market are listed below:
Astellas Pharma
Biogen
Celltech
Eli Lilly and Company
GlaxoSmithKline
Johnson and Johnson
Merck
Novartis
Perdue Pharma
Pfizer
Roche
Sanofi
Shire
Takeda Pharmaceuticals
Thermo Fisher Scientific
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Central Nervous System (CNS) Stimulant Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Central Nervous System (CNS) Stimulant Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Amphetamine
1.2.3 Cocaine
1.2.4 Caffeine
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Central Nervous System (CNS) Stimulant Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.3.3 Narcolepsy
1.3.4 Others
1.4 Global Central Nervous System (CNS) Stimulant Drugs Market Size & Forecast
1.4.1 Global Central Nervous System (CNS) Stimulant Drugs Sales in Value (2016-2026))
1.4.2 Global Central Nervous System (CNS) Stimulant Drugs Sales in Volume (2016-2026)
1.4.3 Global Central Nervous System (CNS) Stimulant Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Central Nervous System (CNS) Stimulant Drugs Production Capacity Analysis
1.5.1 Global Central Nervous System (CNS) Stimulant Drugs Total Production Capacity (2016-2026)
1.5.2 Global Central Nervous System (CNS) Stimulant Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Central Nervous System (CNS) Stimulant Drugs Market Drivers
1.6.2 Central Nervous System (CNS) Stimulant Drugs Market Restraints
1.6.3 Central Nervous System (CNS) Stimulant Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Product and Services
2.1.4 Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business
2.2.3 Biogen Central Nervous System (CNS) Stimulant Drugs Product and Services
2.2.4 Biogen Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Celltech
2.3.1 Celltech Details
2.3.2 Celltech Major Business
2.3.3 Celltech Central Nervous System (CNS) Stimulant Drugs Product and Services
2.3.4 Celltech Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Product and Services
2.4.4 Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Product and Services
2.5.4 GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Product and Services
2.6.4 Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Central Nervous System (CNS) Stimulant Drugs Product and Services
2.7.4 Merck Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Central Nervous System (CNS) Stimulant Drugs Product and Services
2.8.4 Novartis Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Perdue Pharma
2.9.1 Perdue Pharma Details
2.9.2 Perdue Pharma Major Business
2.9.3 Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Product and Services
2.9.4 Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Central Nervous System (CNS) Stimulant Drugs Product and Services
2.10.4 Pfizer Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Roche
2.11.1 Roche Details
2.11.2 Roche Major Business
2.11.3 Roche Central Nervous System (CNS) Stimulant Drugs Product and Services
2.11.4 Roche Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Sanofi
2.12.1 Sanofi Details
2.12.2 Sanofi Major Business
2.12.3 Sanofi Central Nervous System (CNS) Stimulant Drugs Product and Services
2.12.4 Sanofi Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Shire
2.13.1 Shire Details
2.13.2 Shire Major Business
2.13.3 Shire Central Nervous System (CNS) Stimulant Drugs Product and Services
2.13.4 Shire Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Takeda Pharmaceuticals
2.14.1 Takeda Pharmaceuticals Details
2.14.2 Takeda Pharmaceuticals Major Business
2.14.3 Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Product and Services
2.14.4 Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Product and Services
2.15.4 Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Central Nervous System (CNS) Stimulant Drugs Sales by Manufacturer
3.1 Global Central Nervous System (CNS) Stimulant Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Central Nervous System (CNS) Stimulant Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Central Nervous System (CNS) Stimulant Drugs Manufacturer Market Share
3.4.2 Top 6 Central Nervous System (CNS) Stimulant Drugs Manufacturer Market Share
3.5 Global Central Nervous System (CNS) Stimulant Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Central Nervous System (CNS) Stimulant Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Central Nervous System (CNS) Stimulant Drugs Market Size by Region
4.1.1 Global Central Nervous System (CNS) Stimulant Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2016-2026)
4.2 North America Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026)
4.3 Europe Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026)
4.4 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026)
4.5 South America Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026)
4.6 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Central Nervous System (CNS) Stimulant Drugs Sales in Volume by Type (2016-2026)
5.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue by Type (2016-2026)
5.3 Global Central Nervous System (CNS) Stimulant Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Central Nervous System (CNS) Stimulant Drugs Sales in Volume by Application (2016-2026)
6.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue by Application (2016-2026)
6.3 Global Central Nervous System (CNS) Stimulant Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2026)
7.2 North America Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2026)
7.3 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Country
7.3.1 North America Central Nervous System (CNS) Stimulant Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2026)
8.2 Europe Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2026)
8.3 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Country
8.3.1 Europe Central Nervous System (CNS) Stimulant Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Region
9.3.1 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2026)
10.2 South America Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2026)
10.3 South America Central Nervous System (CNS) Stimulant Drugs Market Size by Country
10.3.1 South America Central Nervous System (CNS) Stimulant Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Country
11.3.1 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Central Nervous System (CNS) Stimulant Drugs Typical Distributors
12.3 Central Nervous System (CNS) Stimulant Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Astellas Pharma Major Business
Table 5. Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 6. Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Biogen Basic Information, Manufacturing Base and Competitors
Table 8. Biogen Major Business
Table 9. Biogen Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 10. Biogen Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Celltech Basic Information, Manufacturing Base and Competitors
Table 12. Celltech Major Business
Table 13. Celltech Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 14. Celltech Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 16. Eli Lilly and Company Major Business
Table 17. Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 18. Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 22. GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson and Johnson Major Business
Table 25. Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 26. Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 30. Merck Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 34. Novartis Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Perdue Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Perdue Pharma Major Business
Table 37. Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 38. Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 42. Pfizer Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Roche Basic Information, Manufacturing Base and Competitors
Table 44. Roche Major Business
Table 45. Roche Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 46. Roche Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sanofi Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi Major Business
Table 49. Sanofi Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 50. Sanofi Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Shire Basic Information, Manufacturing Base and Competitors
Table 52. Shire Major Business
Table 53. Shire Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 54. Shire Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Takeda Pharmaceuticals Major Business
Table 57. Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 58. Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 60. Thermo Fisher Scientific Major Business
Table 61. Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Product and Services
Table 62. Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Central Nervous System (CNS) Stimulant Drugs Sales by Manufacturer (2019-2021e) & (MT)
Table 64. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Central Nervous System (CNS) Stimulant Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Central Nervous System (CNS) Stimulant Drugs Production Capacity by Company, (MT): 2020 VS 2021
Table 67. Head Office and Central Nervous System (CNS) Stimulant Drugs Production Site of Key Manufacturer
Table 68. Global Central Nervous System (CNS) Stimulant Drugs Sales by Region (2016-2021e) & (MT)
Table 69. Global Central Nervous System (CNS) Stimulant Drugs Sales by Region (2021-2026) & (MT)
Table 70. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 71. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2021-2026) & (USD Million)
Table 72. Global Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2021e) & (MT)
Table 73. Global Central Nervous System (CNS) Stimulant Drugs Sales by Type (2021-2026) & (MT)
Table 74. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 75. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Type (2021-2026) & (USD Million)
Table 76. Global Central Nervous System (CNS) Stimulant Drugs Price by Type (2016-2021e) & (USD/MT)
Table 77. Global Central Nervous System (CNS) Stimulant Drugs Price by Type (2021-2026) & (USD/MT)
Table 78. Global Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2021e) & (MT)
Table 79. Global Central Nervous System (CNS) Stimulant Drugs Sales by Application (2021-2026) & (MT)
Table 80. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 81. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Application (2021-2026) & (USD Million)
Table 82. Global Central Nervous System (CNS) Stimulant Drugs Price by Application (2016-2021e) & (USD/MT)
Table 83. Global Central Nervous System (CNS) Stimulant Drugs Price by Application (2021-2026) & (USD/MT)
Table 84. North America Central Nervous System (CNS) Stimulant Drugs Sales by Country (2016-2021e) & (MT)
Table 85. North America Central Nervous System (CNS) Stimulant Drugs Sales by Country (2021-2026) & (MT)
Table 86. North America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. North America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. North America Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2021e) & (MT)
Table 89. North America Central Nervous System (CNS) Stimulant Drugs Sales by Type (2021-2026) & (MT)
Table 90. North America Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2021e) & (MT)
Table 91. North America Central Nervous System (CNS) Stimulant Drugs Sales by Application (2021-2026) & (MT)
Table 92. Europe Central Nervous System (CNS) Stimulant Drugs Sales by Country (2016-2021e) & (MT)
Table 93. Europe Central Nervous System (CNS) Stimulant Drugs Sales by Country (2021-2026) & (MT)
Table 94. Europe Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Europe Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Europe Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2021e) & (MT)
Table 97. Europe Central Nervous System (CNS) Stimulant Drugs Sales by Type (2021-2026) & (MT)
Table 98. Europe Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2021e) & (MT)
Table 99. Europe Central Nervous System (CNS) Stimulant Drugs Sales by Application (2021-2026) & (MT)
Table 100. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Region (2016-2021e) & (MT)
Table 101. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Region (2021-2026) & (MT)
Table 102. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 103. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2021e) & (MT)
Table 105. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Type (2021-2026) & (MT)
Table 106. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2021e) & (MT)
Table 107. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Application (2021-2026) & (MT)
Table 108. South America Central Nervous System (CNS) Stimulant Drugs Sales by Country (2016-2021e) & (MT)
Table 109. South America Central Nervous System (CNS) Stimulant Drugs Sales by Country (2021-2026) & (MT)
Table 110. South America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. South America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. South America Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2021e) & (MT)
Table 113. South America Central Nervous System (CNS) Stimulant Drugs Sales by Type (2021-2026) & (MT)
Table 114. South America Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2021e) & (MT)
Table 115. South America Central Nervous System (CNS) Stimulant Drugs Sales by Application (2021-2026) & (MT)
Table 116. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Country (2016-2021e) & (MT)
Table 117. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Country (2021-2026) & (MT)
Table 118. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 119. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Type (2016-2021e) & (MT)
Table 121. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Type (2021-2026) & (MT)
Table 122. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Application (2016-2021e) & (MT)
Table 123. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Application (2021-2026) & (MT)
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Central Nervous System (CNS) Stimulant Drugs Typical Distributors
Table 127. Central Nervous System (CNS) Stimulant Drugs Typical Customers
List of Figures
Figure 1. Central Nervous System (CNS) Stimulant Drugs Picture
Figure 2. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Type in 2020
Figure 3. Amphetamine
Figure 4. Cocaine
Figure 5. Caffeine
Figure 6. Others
Figure 7. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application in 2020
Figure 8. Attention Deficit Hyperactivity Disorder (ADHD)
Figure 9. Narcolepsy
Figure 10. Others
Figure 11. Global Central Nervous System (CNS) Stimulant Drugs Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 12. Global Central Nervous System (CNS) Stimulant Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Central Nervous System (CNS) Stimulant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Central Nervous System (CNS) Stimulant Drugs Sales (2016-2026) & (MT)
Figure 33. Global Central Nervous System (CNS) Stimulant Drugs Production Capacity (2016-2026) & (MT)
Figure 34. Global Central Nervous System (CNS) Stimulant Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Central Nervous System (CNS) Stimulant Drugs Market Drivers
Figure 36. Central Nervous System (CNS) Stimulant Drugs Market Restraints
Figure 37. Central Nervous System (CNS) Stimulant Drugs Market Trends
Figure 38. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Manufacturer in 2020
Figure 39. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Manufacturer in 2020
Figure 40. Central Nervous System (CNS) Stimulant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Central Nervous System (CNS) Stimulant Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Central Nervous System (CNS) Stimulant Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Region (2016-2026)
Figure 44. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Region (2016-2026)
Figure 45. North America Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Europe Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026) & (USD Million)
Figure 48. South America Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Type (2016-2026)
Figure 51. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Type (2016-2026)
Figure 52. Global Central Nervous System (CNS) Stimulant Drugs Price by Type (2016-2026) & (USD/MT)
Figure 53. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application (2016-2026)
Figure 54. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Application (2016-2026)
Figure 55. Global Central Nervous System (CNS) Stimulant Drugs Price by Application (2016-2026) & (USD/MT)
Figure 56. North America Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Country (2016-2026)
Figure 57. North America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Country (2016-2026)
Figure 58. North America Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Type (2016-2026)
Figure 59. North America Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application (2016-2026)
Figure 60. Europe Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Country (2016-2026)
Figure 61. Europe Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Country (2016-2026)
Figure 62. Europe Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Country (2016-2026)
Figure 69. South America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Country (2016-2026)
Figure 70. South America Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の双極性障害治療薬市場 2021：企業別、地域別、種類・用途別 The Bipolar Disorder Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 睡眠障害治療薬の世界市場2018-2025 Sleep Disorder Treatment Drugs are special treatments targeting on medical disorder in which the patient has difficulty with sleep maintenance or sleep initiation.Factors such as increasing incidences of depression and other medical disorders, late night working schedule, busy lifestyle, lack of qua…
- 抗ウイルス薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu. Scope of the Report: This report focuses on the Antiviral Drugs in global market, especially in North America, Europe and Asia-Pacific, Sou…
- 心血管薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cardiovascular Drugs and Therapy is a bimonthly peer-reviewed medical journal covering pharmacotherapy as it relates to cardiology. It was established in 1987 and is published by Springer Science+Business Media on behalf of the International Society of Cardiovascular Pharmacotherapy, of which it is …
- 抗精神病薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Scope of the Report: This report focuses on the An…